High drug-pathogen mismatch in the management of invasive carbapenem-resistant Enterobacteriaceae infections at a tertiary hospital in Nigeria

Author:

Adekanmbi OlukemiORCID,Popoola Oluwafemi,Fowotade Adeola,Idowu OlusolaORCID,Ogunbosi BabatundeORCID,Lakoh Sulaiman,Adebiyi Ini

Funder

Pfizer Inc

University College London Hospitals NHS Foundation Trust

Central and West Africa Implementation Science Alliance

University of Ibadan

West Central Initiative

Publisher

Elsevier BV

Reference10 articles.

1. Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019–2020: an update;Lowe;S Afr Med J,2022

2. World Health Organization. WHO priority pathogens list for R&D of new antibiotics, http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/; 2017 [accessed 13 March 2024].

3. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections;Trecarichi;Virulence,2017

4. Africa Centres for Disease Control and Prevention, Center for Disease Dynamics EP, editor. African antibiotic treatment guidelines for common bacterial infections and syndromes. 1st ed. Addis Ababa: Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy, 2021.

5. The WHO AWaRe (access, watch, reserve) antibiotic book,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3